Economic availability of medicinal products, which affect on structure and mineralization of bones on the pharmaceutical market of Ukraine
Journal Title: Фармацевтичний журнал - Year 2018, Vol 1, Issue 1
Abstract
In recent decades, the problem of osteoporosis has become acute for Ukraine in connection with two demographic processes: a sharp increase in the population of the elderly and senile age and, correspondingly, the number of women in postmenopausal women. At present, the share of the population of Ukraine at the age of 60 years and older is 23.1% (men – 18.1%, women – 27.3%). The number of patients with osteoporosis and its complications is increasing. In connection with this, an analysis of the assortment of medicines affecting the structure and mineralization of bones (bisphosphonates) was carried out. The analysis was conducted during 2014–2016 according to the analytical system of research of the pharmaceutical market «RharmExplorer». For the analysis of socio-economic accessibility of bisphosphonates, an indicator of adequacy of solvency was calculated. In the analysis of the pharmaceutical market in Ukraine the period from 2014 to 2016, 10 INN were installed. In 2014, the market of Ukraine was represented by 41 TN, of which 9 TN of domestic production and 32 TN of foreign production. In 2015, there are 44 TNs, of which 11 TN of domestic production and 33 TN of foreign production. In 2016, there are 40 TNs, of which 12TN of domestic production and 28 TN of foreign production. The obtained data testify that preparations influencing the structure and mineralization of bones are represented on the market in a wide range. During the study period 2014–2016, there were 10 INN drugs on the market, on the basis of which 41, 44 and 40 TNs were represented by years respectively. Analysis of economic accessibility of bisphosphonates showed that the vast majority of them for a course of treatment for 1 month is available for all categories of the population. Only preparations based on zoledronic acid and denzomab are not readily available to the public. In 2016, 100% of alendron acid preparations and 50% of risedron acid preparations were classified as highly available preparations.
Authors and Affiliations
L. V. Iakovlieva, N. A. Matiashova, E. V. Stalna
Keywords
Related Articles
- EP ID EP551743
- DOI 10.32352/0367-3057.1-2.18.01
- Views 64
- Downloads 0
Medical cosmetics in Ukraine: realities and prospects
Cosmetic remedies are significant part of pharmacy institutions. It’s important to take into account pharmacies’ specifics and to provide people having problem skin and the special needs of skin with cosmetic remedies as...
Pharmaceutical development with commercialization of generic drugs with poor soluble substance – tablets of drug nimodipine
The pharmaceutical development of solid dosage forms which containing a poor soluble substance deserves special attention, because a composition and a technology of production such drugs directly effects on release the a...
Experimental study of antimicrobial activity of gel based on PHDP and its combinations with azelaic acid and benzoyl peroxide
The creation of combined medicines for the treatment of dermatological diseases based on the substances of natural origin, in particular phenol-hydrophobic drug propolis with reduced content of benzoyl peroxide and azela...
Motivation of obtaining higher pharmaceutical education of students of the National Pharmaceutical University
Choice of profession is the main factor in the further life of man, his attitude to himself and the world. When choosing a profession, a person is guided by a number of motives. In modern society, the motives of high sc...
Ammonium hexafluorosilicates: a new type of anti-caries agents
It is known that dental caries is one of the most common diseases; for children, this pathology ranks first among chronic diseases and has the character of a pandemic. In the modern arsenal of means for the treatment and...